Reactive oxygen species produced by S100A9 and tumor necrosis factor receptor-associated factor 6 (TRAF6) can activate NLRP3 inflammasome, which eventually leads to the formation of pyroptosis in MDS patients and promotes hematopoietic failure of MDS (56). Here, S100A9 is linked to myelodysplastic syndrome.